April 2012
Cover Story
To paraphrase Mark Twain, the death of the health insurance industry has been greatly exaggerated. Plans simply have to develop new business models.
Health Plan 2020
Health Plan 2020
Health Plan 2020
Health Plan 2020
Q&A
The UC–Berkeley health care economist says the cost-control and performance-improvement methods we’ve been developing for years can work, but implementing them on a wide scale may come as a last resort
Provenge is just one example of an expensive biotechnology drug whose survival analyses leave much to be desired
Treating sleep apnea greatly reduces global costs, but compliance remains a concern
Editor’s Memo
Viewpoint: Employer View
Viewpoint: Health Plan View
Legislation & Regulation
Health plan officials are not doing handstands over the federal government’s extension of a deadline to disclose benefits to members in a readable form
Medication Management
Insurers feel pressure to incorporate new agents into their drug benefit, but evidence of effectiveness is questionable
Evidence Review
A summary of ECRI Institute’s Health Technology Forecast Report
Compensation Monitor
The Formulary Files
Snapshot
Employers and the federal government like these programs, but some question their cost-effectiveness
Tomorrow’s Medicine
There are many genetic mutations attributable to the condition, but Kalydeco can significantly help a specific subpopulation of patients
Managed Care Outlook
Follow us
Today's popular content
- How Doctors Are Paid Now, And Why It Has to Change
- Specialty Pharmacy Management Will Become More Intense
- Through the Looking Glass
- What the Primary Care Physician Shortage Means for Health Plans
- Occupy the OR
- Transparency Called Key To Uniting Cost Control, Quality Improvement
- Health Plans Can Learn From VHA Turnaround
- It's To Plans' Benefit To Spell Out Authority
- Large employers agree on rewarding healthy behavior
- Insurers skeptical of usefulness of companion diagnostics
Recent blog posts
- Health Care Industry’s Moment of Truth Is Approaching
- Through the Looking Glass
- Physician Practices Hiring Care Coordinators
- Who Will Pay for High-Cost Biologics?
- Health exchanges stumble to the starting line
- It's Elementary
- Yet Another Warning About Antibiotic Overprescribing
- Let the EMR Backlash Begin
- Not a Third World Experience
- UK: Health Care Policy Mayhem…and a Very Public Scandal
